jama glp-1 Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are medications that reduce food cravings, increase fullness, slow digestion, and can help control From evidence to action: WHO

Only when B12 injections became available was folate treatment abandoned, leaving many victims with irreversible B12-deficiency-related neurological damage

Present and Future of Weight Loss It may be possible to maintain weight loss while tapering GLP-1 to a lower dosage or prolonging the time between doses [276,277]

Continue standard sun protection habits, because increased melanin does not prevent UV damage

Emerging research also points to the possibility of lowering risks for neurocognitive diseases, offering another promising tool in the fight against conditions such as Alzheimers

Think of it like this your kidney becomes a sugar drain